Abbott Laboratories - Operating Income

Abbott Laboratories's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Operating-Income" stands at 7.76 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2023.

Abbott Laboratories's third quarter result of 2.03 Billion USD for the item "Operating Income" represents a decrease of -1.07 percent compared to it's second quarter result.

Also, Abbott Laboratories's third quarter result of 2.03 Billion USD for the item "Operating Income" represents an increase of 11.66 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Abbott Laboratories's third quarter result of 7.76 Billion USD for the item "Operating Income" represents an increase of 2.81 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.91 percent compared to the value the year prior.
The 1 year change in percent is 14.91.
The 3 year change in percent is -17.16.
The 5 year change in percent is 81.22.
The 10 year change in percent is 169.35.

The Serie's long term average value is 4.86 Billion United States Dollars. It's latest available value, on 09/30/2025, is 59.62 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2017, to it's latest available value, on 09/30/2025, is +295.51%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -24.56%.